Shanghai HAI-NI Pharmaceutical

Shanghai Hai-Ni Pharmaceutical is a prominent pharmaceutical company based in China and operates as a key subsidiary of the Yangtze River Pharmaceutical Group. The company specializes in the research, development, and large-scale manufacturing of finished dosage forms, with a strong focus on therapeutic areas such as gastroenterology, cardiovascular health, and anti-infectives. Its product portfolio includes widely recognized treatments for gastric ulcers and hypertension, produced in state-of-the-art GMP-certified facilities. Shanghai Hai-Ni is integrated into the broader Yangtze River Pharmaceutical ecosystem, leveraging extensive R&D resources to maintain a competitive edge in the domestic Chinese market. The company is committed to high-quality standards and has established itself as a significant player in the industrialization of modern medicine in the Shanghai region.